January 19, 2018 9:11 PM ET

Life Sciences Tools and Services

Company Overview of Quotient Clinical Ltd.

Company Overview

Quotient Clinical Ltd. provides drug development services for pharmaceutical and biotechnology customers worldwide. It offers service packages in the areas of first-in-human to proof of concept, clinical formulation optimization, human ADME, absolute bioavailability, oncology drug development, and clinical pharmacology, as well as support services for various stages of the drug development process. The company was formerly known as Pharmaceutical Profiles Group Ltd. and changed its name to Quotient Clinical Ltd. in May 2009. Quotient Clinical Ltd. was founded in 2004 and is based in Nottingham, United Kingdom.

Mere Way


Nottingham,  NG11 6JS

United Kingdom

Founded in 2004


44 1159 749 000


44 1159 748 000

Key Executives for Quotient Clinical Ltd.

Chief Executive Officer and Managing Director
Chief Financial Officer
Age: 50
Chief Operating Officer
Chief Commercial Officer
Executive Director of Drug Product Optimisation
Compensation as of Fiscal Year 2017.

Quotient Clinical Ltd. Key Developments

Pharmaceutical Product Development, LLC and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

Pharmaceutical Product Development, LLC (PPD) and Quotient Sciences (Quotient) announced a new collaboration to accelerate pediatric drug development. The companies will jointly support pediatric drug development for clients from concept to market launch through a unique end-to-end service that will speed delivery of pediatric medicines. The new service was established in response to increasing customer demand and the drive by key regulatory agencies to promote the development of new medicines for children earlier in the product development life cycle. The collaboration simplifies contracting and delivery by offering clients a single solution for an entire pediatric program, with only one contract and one PPD point of contact. As a result of that structure, the number of handoffs is significantly reduced and the process is much more streamlined, eliminating the delays that often occur when moving from early dosing to later phases.

Quotient Clinical Signs Agreement with Nuformix to Evaluate Cocrystal Formulations Using Translational Pharmaceutics

Quotient Clinical has signed an agreement with Nuformix Technologies Limited, to evaluate the clinical performance of Nuformix’s lead pharmaceutical cocrystal, NXP001, which is based on a currently marketed treatment in the field of oncology supportive care. Pharmaceutical cocrystals are re-engineered crystalline forms of small molecule drugs, in which a drug and excipient are crystallised together. Resulting cocrystals can offer a number of performance improvements, such as solubility and dissolution of otherwise poorly soluble drugs. Under the terms of the agreement, Quotient will use its Translational Pharmaceutics® platform to develop a formulated oral NXP001 cocrystal product and validate its performance in healthy subjects.

Quotient Clinical Appoints Azhar Kalim as Chief Commercial Officer

Quotient Clinical announced the appointment of Azhar Kalim as Chief Commercial Officer (CCO). Azhar will lead the enhanced commercial team in a new role, with a focus on supporting Quotient’s strategy to further develop its global commercial footprint following two recent US acquisitions. Azhar will be responsible for global commercial activities to support Quotient’s integrated services.

Similar Private Companies By Industry

Company Name Region
14M Genomics Ltd Europe
AB-Polyblok Ltd Europe
Ablatus Therapeutics Limited Europe
Accuro Biologics Ltd. Europe
ActinoPharma Limited Europe

Recent Private Companies Transactions

November 13, 2017
PharMaterials Ltd.
February 14, 2017
QS Pharma, LLC
February 6, 2017
Seaview Research, Inc.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Quotient Clinical Ltd., please visit www.quotientclinical.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.